Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
Back to Results
First Page
Meta Content
View Document Preview and Link
XOLAIR® CRITERIA Pharmacology: Omalizumab inhibits the binding of IgE to the high-affinity IgE receptor (FceRI) on the surface of mast cells and basophils. Reduction in surface-bound IgE on FceRI-bearing cells limits th
Add to Reading List
Document Date: 2014-09-11 16:49:00
Open Document
File Size: 24,36 KB
Share Result on Facebook
UPDATE
XOLAIR® CRITERIA Pharmacology: Omalizumab inhibits the binding of IgE to the high-affinity IgE receptor (FceRI) on the surface of mast cells and basophils. Reduction in surface-bound IgE on FceRI-bearing cells limits th